Opioid Antagonist
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Clinical Study to Investigate the Pharmacokinetics of Multiple Repeated Doses of Intranasal Naloxone (NCT04764630) | Food and Drug Administration (FDA) | 2021-03-01 |
| Effects of Intranasal Naloxone on Gambling Urges and Craving in Gambling Disorder (NCT03430180) | Finnish Institute for Health and Welfare | 2018-02-22 |
| Effect of High Dose Naloxone on Secondary Hyperalgesia (NCT01935206) | Rigshospitalet, Denmark | 2013-06-01 |
Track Opioid Antagonist automatically
Every clearance here is in the API, with alerts when new ones post.